HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24

Oncogene

Volumn 35, Issue 42, 2016, Pages 5539-5551

  Teo, W W ^a   Merino, V F ^a   Cho, S ^a   Korangath, P ^a   Liang, X ^a,b   Wu, R C ^a,c   Neumann, N M ^a   Ewald, A J ^a   Sukumar, S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WUHAN UNIVERSITY   (China)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CLAUDIN 7; DOXYCYCLINE; HERMES ANTIGEN; HOX PROTEIN; HOXA5 PROTEIN; MATRIGEL; OCCLUDIN; RETINAL; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HOXA5 PROTEIN, HUMAN; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM CELL; CANCER GROWTH; CELL ADHESION; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL SELF-RENEWAL; CELL TRANSFORMATION; CONTROLLED STUDY; ECTOPIC EXPRESSION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN FUNCTION; STEM CELL; TIGHT JUNCTION; TRANSFORMED CELL LINE; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BREAST TUMOR; CANCER GRADING; CLUSTER ANALYSIS; DISEASE COURSE; DISEASE MODEL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTIGENS, CD24; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL SELF RENEWAL; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HOMEODOMAIN PROTEINS; HUMANS; MICE; NEOPLASM GRADING; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; STEM CELLS;

EID: 84966539111     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.95     Document Type: Article

References (56)

1. Pratt MA, Langston AW, Gudas LJ, McBurney MW. Retinoic acid fails to induce expression of Hox genes in differentiation-defective murine embryonal carcinoma cells carrying a mutant gene for alpha retinoic acid receptor. Differentiation 1993; 53: 105-113.
2. Kondo T, Takahashi N, Muramatsu M. The regulation of the murine Hox-2.5 gene expression during cell differentiation. Nucleic Acids Res 1992; 20: 5729-5735.
3. Zwartkruis F, Kruyt F, van der Saag PT, Meijlink F. Induction of HOX-2 genes in P19 embryocarcinoma cells is dependent on retinoic acid receptor alpha. Exp Cell Res 1993; 205: 422-425.
4. Marshall H, Morrison A, Studer M, Popperl H, Krumlauf R. Retinoids and Hox genes. FASEB J 1996; 10: 969-978.
5. Dubrulle J, McGrew MJ, Pourquie O. FGF signaling controls somite boundary position and regulates segmentation clock control of spatiotemporal Hox gene activation. Cell 2001; 106: 219-232.
6. Alexander T, Nolte C, Krumlauf R. Hox genes and segmentation of the hindbrain and axial skeleton. Annu Rev Cell Dev Biol 2009; 25: 431-456.
7. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10: 361-371.
8. Yan W, Chen Y, Yao Y, Zhang H, Wang T. Increased invasion and tumorigenicity capacity of CD44+/CD24-breast cancer MCF7 cells in vitro and in nude mice. Cancer Cell Int 2013; 13: 13-62.
9. Taylor HS, Vanden Heuvel GB, Igarashi P. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 1997; 57: 1338-1345.
10. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000; 405: 974-978.
11. Chen H, Chung S, Sukumar S. HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol 2004; 24: 924-935.
12. Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103: 11707-11712.
13. Chen H, Zhang H, Lee J, Liang X, Wu X, Zhu T et al. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res 2007; 67: 8007-8013.
14. Laursen KB, Mongan NP, Zhuang Y, Ng MM, Benoit YD, Gudas LJ. Polycomb recruitment attenuates retinoic acid-induced transcription of the bivalent NR2F1 gene. Nucleic Acids Res 2013; 41: 6430-6443.
15. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif 2003; 36: 59-72.
16. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
17. Radisky DC, LaBarge MA. Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2008; 2: 511-512.
18. May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA. Epithelialmesenchymal transition and cancer stem cells: A dangerously dynamic duo in breast cancer progression. Breast Cancer Res 2011; 13: 202.
19. Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L et al. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 2010; 5: e12180.
20. Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K et al. The CD44+/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Res 2008; 10: R53.
21. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH et al. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res 2006; 8: R59.
22. Kay R, Rosten PM, Humphries RK. CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor. J Immunol 1991; 147: 1412-1416.
23. Petkova N, Hennenlotter J, Sobiesiak M, Todenhofer T, Scharpf M, Stenzl A et al. Surface CD24 distinguishes between low differentiated and transit-Amplifying cells in the basal layer of human prostate. Prostate 2013; 73: 1576-1590.
24. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 2006; 8: R7.
25. Thomas S, Harding MA, Smith SC, Overdevest JB, Nitz MD, Frierson HF et al. CD24 is an effector of HIF-1-driven primary tumor growth and metastasis. Cancer Res 2012; 72: 5600-5612.
26. Vesuna F, Lisok A, Kimble B, Raman V. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 2009; 11: 1318-1328.
27. Ghiaur G, Yegnasubramanian S, Perkins B, Gucwa JL, Gerber JM, Jones RJ. Regulation of human hematopoietic stem cell self-renewal by the microenvironment's control of retinoic acid signaling. Proc Natl Acad Sci USA 2013; 110: 16121-16126.
28. Henderson KD, Andrew DJ. Regulation and function of Scr, exd, and hth in the Drosophila salivary gland. Dev Biol 2000; 217: 362-374.
29. Raman V, Tamori A, Vali M, Zeller K, Korz D, Sukumar S. HOXA5 regulates expression of the progesterone receptor. J Biol Chem 2000; 275: 26551-26555.
30. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
31. Ribeiro AS, Paredes J. P-cadherin linking breast cancer stem cells and invasion: A promising marker to identify an "intermediate/metastable" EMT state. Front Oncol 2015; 4: 371.
32. Wang H, Meyer CA, Fei T, Wang G, Zhang F, Liu XS. A systematic approach identifies FOXA1 as a key factor in the loss of epithelial traits during the epithelialto-mesenchymal transition in lung cancer. BMC Genomics 2013; 14: 680.
33. Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F et al. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res 2011; 71: 1292-1301.
34. Qiao Y, Jiang X, Lee ST, Karuturi RK, Hooi SC, Yu Q. FOXQ1 regulates epithelialmesenchymal transition in human cancers. Cancer Res 2011; 71: 3076-3086.
35. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007; 1: 84-96.
36. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17: 1253-1270.
37. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 393-403.
38. Wang YA, Shen K, Wang Y, Brooks SC. Retinoic acid signaling is required for proper morphogenesis of mammary gland. Dev Dyn 2005; 234: 892-899.
39. Aubin J, Lemieux M, Tremblay M, Berard J, Jeannotte L. Early postnatal lethality in Hoxa-5 mutant mice is attributable to respiratory tract defects. Dev Biol 1997; 192: 432-445.
40. Tokes AM, Kulka J, Paku S, Szik A, Paska C, Novak PK et al. Claudin-1,-3 and-4 proteins and mRNA expression in benign and malignant breast lesions: A research study. Breast Cancer Res 2005; 7: R296-R305.
41. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22: 2021-2033.
42. Swisshelm K, Machl A, Planitzer S, Robertson R, Kubbies M, Hosier S. SEMP1, a senescence-Associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily. Gene 1999; 226: 285-295.
43. Kramer F, White K, Kubbies M, Swisshelm K, Weber BH. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 2000; 107: 249-256.
44. Martin TA, Mansel RE, Jiang WG. Loss of occludin leads to the progression of human breast cancer. Int J Mol Med 2010; 26: 723-734.
45. Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, Rudnick JA et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res 2010; 12: R87.
46. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stemcell-like properties. Cell 2013; 152: 25-38.
47. Ginestier C, Wicinski J, Cervera N, Monville F, Finetti P, Bertucci F et al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 2009; 8: 3297-3302.
48. Ansari KI, Hussain I, Kasiri S, Mandal SS. HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4. J Mol Endocrinol 2012; 48: 61-75.
49. Sun R, Liu Y, Li SY, Shen S, Du XJ, Xu CF et al. Co-delivery of all-Trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells. Biomaterials 2015; 37: 405-414.
50. Arab HH, Wani G, Ray A, Shah ZI, Zhu Q, Wani AA. Dissociation of CAK from core TFIIH reveals a functional link between XP-G/CS and the TFIIH disassembly state. PLoS One 2010; 5: e11007.
51. Jin K, Park S, Teo WW, Korangath P, Cho SS, Yoshida T et al. HOXB7 is an ERalpha cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance. Cancer Discov 2015; 5: 944-959.
52. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268.
53. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004; 101: 4966-4971.
54. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
55. Jin K, Kong X, Shah T, Penet MF, Wildes F, Sgroi DC et al. The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci USA 2012; 109: 2736-2741.
56. Thiaville MM, Stoeck A, Chen L, Wu RC, Magnani L, Oidtman J et al. Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites. PLoS One 2012; 7: e36054.